Clinical Trials Directory

Trials / Completed

CompletedNCT04316871

Dosage of Epidural Morphine in Elderly Patients

Epidural Morphine for Geriatrics Undergoing Lower Abdominal Cancer Surgery: a Dose Response Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
96 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
60 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This a clinical trial that evaluates the efficacy and safety of three different doses of morphine, namely 1.5 mg, 3 mg and 4.5 mg, via the epidural route regarding reducing pain in elderly patients after a cancer surgery in the lower abdomen

Detailed description

Acute postoperative pain is a common complaint for several days after surgery. However, acute postoperative pain remains even more under controlled in elderly patients, especially those with cognitive impairment and malignancy. Geriatric population is reported to be at higher risk for unwanted side effects from analgesic treatments compared to younger patients due to different major risk factors such as: decline in organ function, polypharmacy, pharmacokinetics, drug sensitivity, and frailty. Despite of the higher risk of opioids, especially morphine, causing toxicity and adverse effect; they are still the cornerstone treatment of severe acute postoperative pain. Morphine in those patients is very likely to cause toxicity because of accumulation of its active metabolites compared to other opioids with fewer or no active metabolites. Epidural morphine is an effective route for an effective drug. Furthermore, unwanted side effects with neuraxial opioids are minor and managed easily. Regarding clinical outcomes, clinical studies showed a lot of improvements associated with postoperative opioid analgesia. Now, there is a clinical necessity to achieve the best management of acute postoperative pain in elderly patients with the least possibility of adverse side effects. We aim in this randomized, assessor blinded, clinical trial at Assuit University to determine the optimum dose of epidural morphine for the highest control of acute postoperative pain in geriatrics who are planned to have lower abdominal cancer surgery.

Conditions

Interventions

TypeNameDescription
DRUG1.5 mg of Morphine Sulfate1.5 mg of Morphine Sulphate will be given epidurally.
DRUGNormal salineNormal saline will be given epidurally.
DRUG3 mg of Morphine Sulfate3 mg of Morphine Sulphate will be given epidurally.
DRUG4.5 mg of Morphine Sulfate4.5 mg of Morphine Sulphate will be given epidurally.

Timeline

Start date
2020-03-20
Primary completion
2020-12-31
Completion
2021-06-30
First posted
2020-03-20
Last updated
2025-03-05
Results posted
2025-03-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04316871. Inclusion in this directory is not an endorsement.